Thaçi, D <br/><br/>
Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study.  [electronic resource] 

 -  The British journal of dermatology  12 2019 
 - 1177-1189 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1365-2133 
<br/><br/><label>Standard No.: </label>10.1111/bjd.18029  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--administration & dosage<br/>Adolescent<br/>Biological Factors--administration & dosage<br/>Child<br/>Child, Preschool<br/>Chronic Disease--drug therapy<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Long-Term Care--methods<br/>Male<br/>Methotrexate--administration & dosage<br/>Psoriasis--diagnosis<br/>Severity of Illness Index<br/>Time Factors<br/>Treatment Outcome